Print This
‹‹ Go Back

David M. Anderson, DVM

Executive Director, Health Sciences Administration, University of Washington

Dr. David Anderson, DVM, is the Executive Director for Health Science Administration and a Clinical Associate Professor in the Department of Comparative Medicine, University of Washington. Dr. Anderson's early career focused on development and utilization of nonhuman primate models of infectious disease while at the Washington National Primate Research Center. Dr. Anderson continued his work in animal models while taking additional responsibilities related to administration of the animal care and research program, finally resulting in his appointment as Director of the Primate Center. Following many years in this position, he was selected for his current position as Executive Director while also serving as the University Institutional Official. Part of his responsibilities include oversight over the University of Washington's large and diverse animal care, research, and education program through the Office of Animal Welfare. Additional responsibilities include campus health and safety, risk management, compliance, academic support, student health care, and elements of interdiscilinary research. The University of Washington holds one of the largest academic research portfolios in the world, approximately one-third of which involves animal models. Dr. Anderson is one of many University staff committed to supporting outstanding biomedical research in a framework which respects and safeguards animal welfare.

‹‹ Go Back

Rhonda Wiler, DVM

Sr. Director, Genentech



‹‹ Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

Hot Topics and Emerging Trends Track

Breakout Sessions – Series D

D5 - Scientific and Ethical Considerations on the Use of Gene Editing Technologies to Modify Animal Genomes for Research: What IACUCs Should Know

Saturday, April 2

10:30 AM - 11:45 AM

Faculty(s):

David M. Anderson, DVM

Executive Director, Health Sciences Administration, University of Washington

Rhonda Wiler, DVM

Sr. Director, Genentech

Join the Institute for Laboratory Animal Research Roundtable members for a session on gene editing in research animals and its impact on IACUCs, which was inspired by a workshop held on December 7-8, 2015, in Washington, DC. During that workshop, members examined science, policy, and ethical challenges from the widespread use of gene editing technologies, such as CRISPR/Cas9, TALENS, and “zinc fingers.” During this session, faculty and attendees will:


  • Discuss the science and ethical and welfare issues behind gene editing
  • Outline how these technologies would change the use of animal models and how the optimal models for research would be chosen
  • Explore the potential effect gene editing could have on expanding the numbers of animals and variety of species that could be used in biomedical research
  • Address the ethical issues that should be considered before expanding the use of these technologies in animal species that are not currently used in biomedical research
Slides